-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$982,233 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Greenwich LifeSciences, Inc. Insider Transactions
Greenwich LifeSciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $9.49 | $2,373 | 259,248 | 07/13/2023 | 07/17/2023 | |
|
Patel Snehal
CEO |
Buy | 1,000 @ $11.69 | $11,690 | 5,287,177 | 05/17/2023 | 05/18/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $11.22 | $2,805 | 258,998 | 04/28/2023 | 05/02/2023 | |
|
Patel Snehal
CEO |
Buy | 7,000 @ $11.10 | $77,700 | 5,286,177 | 04/19/2023 | 04/21/2023 | |
|
Patel Snehal
CEO |
Buy | 2,000 @ $11.12 | $22,240 | 5,279,177 | 04/18/2023 | 04/20/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 1,000 @ $11.87 | $11,870 | 258,745 | 04/11/2023 | 04/12/2023 | |
|
Patel Snehal
CEO |
Buy | 5,000 @ $12.42 | $62,100 | 5,271,177 | 04/11/2023 | 04/12/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $12.71 | $3,178 | 257,745 | 03/15/2023 | 03/16/2023 | |
|
Patel Snehal
CEO |
Buy | 1,000 @ $12.12 | $12,120 | 2,737,486 | 03/10/2023 | 03/13/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $15.40 | $3,849 | 257,495 | 02/24/2023 | 02/28/2023 | |
|
Patel Snehal
CEO |
Buy | 600 @ $16.53 | $9,918 | 2,736,486 | 02/17/2023 | 02/22/2023 | |
|
Patel Snehal
CEO |
Buy | 1,000 @ $18.68 | $18,680 | 2,735,886 | 02/10/2023 | 02/14/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $20.84 | $5,210 | 257,245 | 02/03/2023 | 02/07/2023 | |
|
Patel Snehal
CEO |
Buy | 2,000 @ $19.35 | $38,700 | 2,734,886 | 01/27/2023 | 01/31/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $19.20 | $4,800 | 256,995 | 01/27/2023 | 01/30/2023 | |
|
Patel Snehal
CEO |
Buy | 1,500 @ $17.37 | $26,055 | 2,732,886 | 01/20/2023 | 01/24/2023 | |
|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $16.50 | $4,125 | 256,745 | 01/13/2023 | 01/17/2023 | |
|
Patel Snehal
CEO |
Buy | 1,500 @ $15.18 | $22,770 | 2,731,386 | 01/06/2023 | 01/10/2023 | |
|
Patel Snehal
CEO |
Buy | 4,000 @ $15.19 | $60,760 | 2,729,886 | 12/29/2022 | 01/03/2023 | |
|
Patel Snehal
CEO |
Buy | 1,000 @ $13.01 | $13,010 | 2,725,886 | 12/16/2022 | 12/20/2022 |
Greenwich LifeSciences, Inc. Frequently Asked Questions
-
Who is on Greenwich LifeSciences, Inc.'s Insider Roster?
The list of insiders at Greenwich LifeSciences, Inc. includes Patel Snehal, Thompson Jaye.
-
How much insider buying is happening at Greenwich LifeSciences, Inc.?
Insiders have purchased a total of 82,100 Greenwich LifeSciences, Inc. shares in the last 12 months for a total of 982,233 sold.
-
Which Greenwich LifeSciences, Inc. insiders have been buying company stock?
The following insiders have purchased Greenwich LifeSciences, Inc. shares in the last 12 months: Patel Snehal ($977,948), Thompson Jaye ($4,285),